Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist

Islet transplantation is a feasible therapeutic alternative for metabolically labile patients with type 1 diabetes. The primary therapeutic target is stable glycemic control and prevention of complications associated with diabetes by reconstitution of endogenous insulin secretion. However, critical...

Full description

Bibliographic Details
Main Authors: Ludwig, Barbara (Author), Rotem, Avi (Author), Schmid, Janine (Author), Weir, Gordon C. (Author), Colton, Clark K. (Contributor), Brendel, Mathias D. (Author), Neufeld, Tova (Author), Block, Norman L. (Author), Yavriyants, Karina (Author), Steffen, Anja (Author), Ludwig, Stefan (Author), Chavakis, Triantafyllos (Author), Reichel, Andreas (Author), Azarov, Dmitri (Author), Zimermann, Baruch (Author), Maimon, Shiri (Author), Balyura, Maria (Author), Rozenshtein, Tania (Author), Shabtay, Noa (Author), Vardi, Pnina (Author), Bloch, Konstantin (Author), de Vos, Paul (Author), Schally, Andrew V. (Author), Bornstein, Stefan R. (Author), Barkai, Uriel (Author)
Other Authors: Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor)
Format: Article
Language:English
Published: National Academy of Sciences, 2012-11-07T21:28:18Z.
Subjects:
Online Access:Get fulltext